-

Guardian Pharmacy Services, Inc. to Participate in Upcoming Jefferies Healthcare Services Investor Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Jefferies Healthcare Services Conference in Nashville, TN, on Tuesday, September 30, 2025. The company will host investor meetings, and Fred Burke, Co-founder and Chief Executive Officer, will take part in a fireside chat with Jefferies analyst, Brian Tanquilut, at 3:35 p.m. CT (4:35 p.m. ET) the same day.

A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be accessible shortly after the event and will remain available for 90 days.

About Guardian Pharmacy Services

Guardian Pharmacy Services is one of the nation’s leading long-term care pharmacy services companies. Through its locally‑based business model, Guardian partners with long-term care facilities (“LTCFs”) to deliver medications and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. With a growing network of more than 52 pharmacies nationwide, Guardian is dedicated to providing exceptional service to over 195,000 residents and approximately 7,400 LTCFs across 38 states (as of June 30, 2025).

Contacts

Investor Contact
Ashley Stockton
Senior Director, Investor Relations
IR@guardianpharmacy.net

Industry:

Guardian Pharmacy Services, Inc.

NYSE:GRDN
Release Versions
English

Contacts

Investor Contact
Ashley Stockton
Senior Director, Investor Relations
IR@guardianpharmacy.net

More News From Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services Announces Pricing of Upsized Underwritten Public Offering of Class A Common Stock

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the pricing of its upsized underwritten public offering (the “Offering”) of 6,000,000 shares of its Class A common stock at a public offering price of $31.00 per share, of which 4,980,000 shares will be sold by certain selling stockholders and 1,020,000 shares will be issued and sold by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the sel...

Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the launch of a proposed underwritten public offering (the “Offering”) of 5,000,000 shares of its Class A common stock, consisting of 3,980,000 shares being offered by certain selling stockholders and 1,020,000 newly issued shares being offered by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the selling stockholders intend to grant the un...

Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the fourth quarter and full year ended December 31, 2025. The Company also raised its full-year 2026 Adjusted EBITDA guidance. Fourth Quarter Financial Results Revenue of $397.6 million, up 17% year-over-year with organic growth of 12%. Residents served ended the quarter at approximately 205,000, up 10%...
Back to Newsroom